Design of Polyamine-Grafted Starches for Nucleotide Analogue Delivery: In Vitro Evaluation of the Anticancer Activity by E. Kanber et al.
Design of Polyamine-Grafted Starches for Nucleotide
Analogue Delivery: In Vitro Evaluation of the Anticancer
Activity
Submitted by Elise Lepeltier on Wed, 10/19/2016 - 12:23
Titre Design of Polyamine-Grafted Starches for Nucleotide Analogue Delivery: In VitroEvaluation of the Anticancer Activity
Type de
publication Article de revue
Auteur Kanber, Erdem [1], Yamada, Hiroe [2], Loretz, Brigitta [3], Lepeltier, Elise [4], Lehr,Claus-Michael [5]
Pays Etats-Unis
Editeur American Chemical Society
Ville Washington
Type Article scientifique dans une revue à comité de lecture
Année 2016
Langue Anglais
Date 2016
Numéro 10
Pagination 2431–2440
Volume 27
Titre de la
revue Bioconjugate Chemistry
ISSN 1043-1802
Résumé en
anglais
Nucleotide analogues are a therapeutic class that is very promising and currently
used in clinics, notably against viral infectious diseases and cancer. However, their
therapeutic potential is often restricted by a poor stability in vivo, the induction of
severe side effects, and limited passive intracellular diffusion due to their
hydrophilicity. Polysaccharide-based polymers (e.g., starch) have considerable
advantages, including a lack of toxicity and the absence of antigenicity. The aim of
this study was to develop new cationic starches able to form complexes with
nucleotide analogues, thus protecting them and increasing their cell uptake. At the
same time, the material should demonstrate good biocompatibility and low
cytotoxicity. Different polyamines, (TREN, TEPA, and spermine) were grafted to
starch to evaluate the impact of side-chain properties. The resulting cationic starch
derivatives were characterized (e.g., degree of modification) and compared in their
ability to form polyplexes with ATP as a model nucleotide. Among the tested
candidates, the formulation of starch–TEPA and ATP with an N/P ratio of 2 led to
nanoparticles with a size of 429 nm, a PdI of 0.054, and a ζ potential of −9 mV. MTT
and LDH assays on A549 cell line showed low toxicity for this polymer. Confocal
microscopy study proved that the cell internalization was an incubation-time- and
energy-dependent process. Most important, starch–TEPA complexed with ddGTP
showed significant biological activity on A549 cancer cells compared to that of plain
ddGTP at the same concentration.
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